Pharmafile Logo
Pharmafocus logo
Advanced Search

Merck enlist Avenue for Erbitux launch

July 22, 2004

Merck UK has launched its first cancer treatment, Erbitux, with a communications programme led by Avenue HKM.Avenue was selected after …

News

Targets out and standards in for next NHS three-year plan

July 22, 2004

The government has unveiled its masterplan for the NHS in the three years from 2005/6, slashing the number of national …

News

Falling stars blight NHS performance ratings

July 21, 2004

Four of the government's flagship foundation trusts have lost their three star ratings in the latest review, prompting further criticism …

News

New Europe: always read the label

July 21, 2004

In May 2004, ten emerging economies across the east of Europe became members of the European Union. This might seem …

Feature

Half a million asthma patients suffering unnecessarily

July 20, 2004

More than half a million people in the UK suffer an asthma attack every day, with a further million putting …

News

Market research in action

July 19, 2004

Market research is to marketing as water is to life. This deeply held view is rooted in the personal belief …

Feature

Framework to promote pharma-NHS partnerships launched

July 15, 2004

A framework to facilitate greater collaboration between the pharma industry and the NHS has been launched by the ABPI in …

News

Vaccine to help smokers kick the habit shows promise

July 15, 2004

A vaccine designed to help smokers kick the habit has shown promise in its second phase I trial, boosting shares …

News

AstraZeneca appoints new global head of product PR

July 15, 2004

AstraZeneca has appointed a new head of global public relations to oversee strategic public relations programmes and all other aspects …

News

Pfizer seizes initiative with US drug discount programme

July 15, 2004

Pfizer will offer drug discounts to the 43 million Americans without health insurance as it seeks to rebuild its image …

News

Embarrassing problem to become marketing battleground

July 15, 2004

News

Lilly’s ‘Cialis Promise’ increases pressure on Viagra

July 15, 2004

The battle for erectile dysfunction market dominance is intensifying in the US with Lilly using consumer-style promotional offers to help …

News

A marriage of inconvenience?

July 14, 2004

Feature

Severe asthma treatment Xolair filed in Europe

July 8, 2004

News

Atacand filed for heart failure in US

July 8, 2004

AstraZeneca has submitted its cardiovascular drug Atacand for an additional US licence to treat heart failure.Atacand (candesartan) is one of …

News

Pfizer’s next blockbuster Lyrica receives European approval

July 8, 2004

Pfizer's potential central nervous system blockbuster Lyrica (pregabalin) has received European marketing approval.The drug has received licences for the treatment …

News

Pfizer UK recruiting for new customer-focused salesforce

July 8, 2004
NHS, Pfizer, salesforce

 Pfizer has unveiled a new, restructured UK sales team designed to meet the needs of the NHS by aligning its …

News

Everyday diseases and everyday solutions

July 8, 2004

What is all the fuss about chronic disease management? Go to virtually any NHS conference these days and you will …

Feature

Growing doubts over reliability of HRT trial conclusions

July 6, 2004

Influential publicly-funded trials into HRT which convinced millions of women to stop taking the treatment could be flawed, researchers from …

News

Labour stakes its reputation on NHS Plan part II

July 6, 2004

The government has unveiled a plan for the second half of the 10-year period covered by the NHS Plan, claiming …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026